Bayer

(IN BRIEF) Covestro has announced a change in leadership on its Supervisory Board following the completion of its strategic partnership with XRG. Dr. Rainer Seele was elected Chairman on 18 December 2025 and assumed the role on 20 December, succeeding … Read the full press release →

(IN BRIEF) Evotec SE announced that Bayer has initiated a Phase 2 clinical study for BAY 3401016, a Semaphorin-3A-targeting monoclonal antibody being developed as a potential therapeutic option for patients with Alport syndrome. As part of the companies’ kidney disease … Read the full press release →

(IN BRIEF) A new expert-led publication in the European Medical Journal, supported by Bayer, highlights the growing global burden of allergic rhinitis (hay fever) among children. Affecting 20% of children worldwide, the condition is linked to reduced academic performance, poor … Read the full press release →

(IN BRIEF) Bayer has officially opened a modern laboratory in Darmstadt, Germany, designed to accelerate research and development in phytomedicines and biotics, with a particular focus on Iberogast and future plant-based health innovations. The facility will enable rapid prototyping, foster … Read the full press release →

(IN BRIEF) Selex Gruppo Commerciale has signed a renewable energy purchase agreement with Iberdrola for 1,250 GWh of photovoltaic power, equal to 125 GWh annually from plants with 77 MW of capacity starting in July 2026. The PPA features a … Read the full press release →

(IN BRIEF) Covestro has appointed Annie Chen as the new Managing Director of Covestro Taiwan, effective 1 September 2025. Currently Head of Supply Chain and Logistics for Taiwan, Korea, New Zealand, and Australia, Chen succeeds Dr. Carsten Wildebrand, who will … Read the full press release →

(IN BRIEF) Bayer has filed for EU approval of icafolin‑methyl, its first new herbicide mode of action in over 30 years, after earlier submissions in Brazil, the U.S., and Canada. With peak sales estimated at €750 million, icafolin‑methyl is slated for … Read the full press release →

(IN BRIEF) ABN AMRO has nominated veteran executive Daniel Hartert to its Supervisory Board for a four‑year term, replacing Arjen Dorland. The appointment, subject to European Central Bank approval, will be decided at an EGM on 11 September 2025, with details posted at … Read the full press release →

(IN BRIEF) Bayer and M2i Group have extended their distribution partnership to cover Asia-Pacific, Latin America, and the United States, following a successful 2023 agreement in Europe and Africa. This exclusive deal will enable Bayer to market M2i’s pheromone gel … Read the full press release →

(IN BRIEF) Iberdrola España and Renfe have signed a 10-year VPPA to supply 370 GWh per year of onshore wind energy—equivalent to a 190 MW wind farm—granting Renfe long-term price stability and advancing Spain’s green transition. The pact will cut … Read the full press release →

(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release →